JULIE HSIA practices in the IP Litigation practice in the firm’s New York office. Her practice focuses on patent litigation. Julie represents clients involving a variety of technologies including biologics and medical devices. She has experience with all phases of litigation including pre-suit diligence, discovery, trial, and appeal.
Representative matters include:
- Representing a major pharmaceutical company in multiple patent suits in the District of Delaware involving replacement Factor VIII products, including obtaining a jury trial victory on the patent owner’s behalf on all asserted claims that resulted in a damages award of over US$150 million. This victory won LMG Life Sciences’ 2019 “Patent Impact Case of the Year” and was named to The National Law Journal’s 2021 “Verdicts Hall of Fame.”
- Representing a medical device company in multiple patent and trade secret litigations in the District of Delaware involving spinal cord stimulation devices.
Julie’s pro bono work includes assisting inmates facing civil rights violations and drafting compassionate release motions related to the COVID-19 pandemic.
While attending Columbia Law School, Julie served as a notes editor for the Columbia Business Law Review. She also interned for Magistrate Judge Orenstein of the Eastern District of New York.
Julie received her B.A. in chemistry and molecular biology and biochemistry from Wesleyan University.